Our current research highlights that SMAR1 is a substrate in the Wnt3a driven proteasomal degradation and restoration of SMAR1 inhibits tumor growth by down-modulating Wnt/β-catenin signaling activities. The gene discussed is WNT3A; the disease is neoplasm.